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Purified human serum butyrylcholinesterase ( % 90-kDa subunit) is known to exhibit aryl acylamidase and 
peptidase activity. Limited a-chymotrypsin digestion of the purified butyrylcholinesterase gave three major protein 
fragments of % 50 kDa, % 21 kDa and M 20 kDa. In our earlier studies [Rao and Balasubramanian (1989) Eur. 
J .  Biochem. 179, 639-6441 we characterized the % 20-kDa fragment and showed that it exhibited both 
butyrylcholinesterase and aryl acylamidase activities. In the present studies the z 50-kDa fragment is characterized. 
This fragment, after isolation by Sephadex G-75 chromatography from a chymotryptic digest of purified 
butyrylcholinesterase, exhibited only peptidase activity and was devoid of cholinesterase and aryl acylamidase 
activities. It could bind to a column of Ricinus communis agglutinin bound to Sepharose, indicating its glycosylated 
nature and the presence of galactose. The peptidase activity in the % 50-kDa fragment could be immuno- 
precipitated by a polyclonal antibody raised against purified butyrylcholinesterase. SDS-gel electrophoresis of 
this fragment isolated by R. communis agglutinin - Sepharose and Sephadex G-75 chromatography showed a 
protein band of % 50 kDa by silver staining. Amino-terminal sequence analysis of the % 50-kDa fragment gave the 
sequence of Gly-Pro-Thr-Val-Asp which corresponded to amino acid residues 291 - 295 in the butyrylcholinesterase 
sequence [Lockridge et al. (1987) J .  Biol. Chem. 262, 549-5571, The combined results suggested that a- 
chymotrypsin digestion of human serum butyrylcholinesterase resulted in the formation of a % 20-kDa fragment 
exhibiting both cholinesterdse and aryl acylamidase activities and a % 50-kDa fragment exhibiting only peptidase 
activity. 
Human serum butyrylcholinesterase (BtChE) is a tetramer 
with a subunit of % 90 kDa [l]. The enzyme is a glycoprotein 
with galactose and mannose as the major neutral sugar resi- 
dues [2]. Purified human serum BtChE is known to exhibit an 
aryl acylamidase activity [3, 41 and a peptidase activity [5]. 
The presence of both these activities on purified human serum 
BtChE was demonstrated by their identical behaviour on 
column chromatographic and affinity chromatographic pro- 
cedures, gel filtration, gel electrophoresis and their co-precipi- 
tation at different dilutions of antibody raised against purified 
BtChE. In our earlier report [6] we showed that limited a- 
chymotrypsin digestion of purified human serum BtChE re- 
sults in the formation of three major fragments, of % 20 kDa, 
z 21 kDa and % 50 kDa, as observed by SDS-gel electro- 
phoresis. Of the two low-molecular-mass fragments, the % 20- 
kDa one is enzymatically active and exhibits both BtChE and 
aryl acylamidase activities. Sequencing of amino acids from 
the amino terminal showed that the z 20-kDa fragment had 
the sequence Arg-Val-Gly-Ala-Leu that fits in with amino acid 
residues 147 ~ 151 in the BtChE sequence given by Lockridge 
[2]. In this report we demonstrate that the % 50-kDa fragment 
resulting from a-chymotrypsin digestion of purified human 
serum BtChE exhibits the peptidase activity. N-terminal se- 
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quence analysis of this M 50-kDa protein fragment showed 
the sequence Gly-Pro-Thr-Val-Asp corresponding to the 
amino acid residues 291 - 295 in the BtChE sequence. Further, 
the comparative characteristics of the intact BtChE, z 20- 
kDa and % 50-kDa protein fragments and active-site labelling 
are also described. 
MATERIALS AND METHODS 
Materials 
a-Chymotrypsin (treated with N"-tosyl-L-lysine chloro- 
methane), chicken egg white trypsin/chymotrypsin inhibitor 
and Bolton-Hunter reagent [N-succinimidyl-3-(4-hydroxy- 
phenyl) propionate] were purchased from Sigma Chemical 
Co. USA. Ricinus communis agglutinin 120 (RCA1) was 
purified from R. communis beans and coupled to Sepharose 4B 
as described earlier [6, 71. [3H]Diisopropyl fluorophosphate, 
from Amersham International, was a kind gift from Dr K. S. 
Krishnan (Tata Institute of Fundamental Research, Bombay). 
Sodium [1251]iodide in dilute NaOH was obtained from 
Bhabha Atomic Research Centre, Bombay. Other chemicals 
were procured as described earlier [3]. 
Purijication of human serum BtChE 
BtChE was purified by the procedure described earlier 
[8] involving DEAE-cellulose and procainamide - Sepharose 
affinity chromatography. 
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a-Chymotrypsin digestion 
Proteolysis was performed essentially as described earlier 
[6). In brief, the purified human serum BtChE was digested 
with a-chymotrypsin (BtChE/chymotrypsin = 1 : 0.01, by 
mass) in a 0.2-ml reaction mixture containing 100 mM Tris/ 
HCl, 1 mM EDTA, pH 7.5. After incubation at 37°C for 
6 h, the reaction was terminated by the addition of the 
chymotrypsin inhibitor. 
Digestion with immobilized chymotrypsin 
Chymotrypsin was immobilized on Sepharose 4B by cou- 
pling 5 mg chymotrypsin to 5 ml cyanogen-bromide-activated 
Sepharose 4B [9]. The washed gel was packed in a column 
(1.6 x 2 cm) and equilibrated with 20 mM phosphate pH 7.2. 
Purified BtChE (0.5 ml) was introduced into the gel, incubated 
for the desired period at 37°C and eluted with the same buffer. 
Labelling with 13H]iPr2P-F 
Purified serum BtChE (50- 100 pg at a concentration of 
4 pg/O.l ml) was allowed to react with a slight molar excess 
of [3H]iPr2P-F (specific activity 3.5 Ci/mmol) and kept at 
4°C for 5 days to achieve aging. The free [3H]iPr,P-F was 
separated from the bound by passing the sample through a 
Sephadex (3-75 column followed by dialysis at 4°C of the 
pooled active fractions against distilled water. Preferential 
labelling of esteratic and non-esteratic sites was done accord- 
ing to Small and Chubb [lo]. In order to label the esteratic 
site of BtChE preferentially, purified BtChE was incubated 
with [3H]iPr2P-F for only 20 min. The non-esteratic site was 
labelled preferentially by pre-incubating BtChE for 1 h with 
200 pM eserine to block the esteratic site. [3H]iPr2P-F was 
then added and the incubation continued for 3 h. After incu- 
bation, the reaction mixture was applied onto the Sephadex 
G-75 column to separate bound radioactivity from free 
[3H]iPr2P-F. 
Iodination of purified BtChE 
Iodination was carried out as described by Bolton and 
Hunter [l 11. Crystalline N-succinimidyl 3-(4-hydroxy- 
pheny1)propionate (0.25 pg) was treated with 10 pl (1.4 mCi) 
of '''I and 50 pl(1 mg/ml) chloramine Tin 20 mM potassium 
phosphate pH 7.5. The reaction was terminated by the ad- 
dition of 120 pl (1 mg/ml) sodium metabisulphite in the same 
buffer, followed by the addition of 5 p1 dimethyl formamide. 
The hydroxysuccinimide ester was extracted into benzene and 
recovered by evaporation of the solvent under vacuum. 
Purified human serum BtChE (10 pg in 10 pl 0.1 M borate 
pH 8.5) was added to the dried iodinated ester and 12'1- 
labelled BtChE was separated from the other labelled products 
of the conjugation reaction by applying the sample on a 
Sephadex G-75 column. 
SDS/polyacrylamide gel electrophoresis 
Samples were boiled for 3 min in the protein dissociation 
buffer (0.186 M Tris/HCl pH 7.6, 6% 2-mercaptoethanol, 
20% glycerol, 6% SDS and 0.001% bromophenol blue) and 
analyzed on 10% sodium dodecyl sulphate/polyacrylamide 
slab gels [6] according to Laeinmli [12]. The gels were fixed 
and stained with Coomassie brilliant blue R or silver nitrate 
[13]. Alternatively, after destaining the Coomassie-blue- 
stained gels in acetic acid/water/methanol (10: 40: 50, by vol.), 
the gel was dried on a gel drier and autoradiography was 
carried out by keeping the dried gel in contact with a Curix 
X-ray film at - 20 "C for 5 - 8 days. The [3H]iPr2P-labelled 
BtChE on the gel was detected fluorographically according to 
Skinner and Griswold [14]. The gels were soaked in acetic acid 
for 5 min, transferred to 20% (massjvol.) PPO in acetic acid 
for 2 h, again soaked in water for 30 min, dried and kept in 
contact with X-ray film at -7O'C for 12 days. 
Sephadex G-75 gel filtration 
A 0.5-ml sample was applied on a Sephadex (3-75 column 
(36 x 1 .I  cm) pre-equilibrated with 20 mM potassium phos- 
phate pH 7.2 containing 0.05 M NaCI. Elution was carried 
out by the same buffer at a flow rate of 4ml/h and 1-ml 
fractions were collected. Each fraction, after dialysis against 
20 mM phosphate pH 7.2, was assayed for the enzyme activi- 
ties. 
RCA ,-Sepharose chromatography 
Samples (0.5 ml) were applied onto an RCAl-Sepharose 
column (3.5 x 1.1 cm) pre-equilibrated with 20 mM potassium 
phosphate pH 7.2, washed with the same buffer and eluted 
with 0.5 M lactose, 1 M NaCI, 20 mM potassium phosphate 
pH 7.2. Fractions of 1 ml were collected. 
Immunological studies 
Antibody against purified BtChE was raised in a rabbit 
and purified by DEAE-cellulose chromatography as described 
earlier [3]. Immunoprecipitation was performed by cross-re- 
acting different concentrations of antibody with the enzyme 
in 0.4 mi 20 mM potassium phosphate pH 7.2. After incu- 
bation at 4°C for 24 h, the samples were centrifuged at 
30000 x g for 30 min and the supernatant was assayed for the 
enzyme activity. 
Amino-terminal sequence analysis 
Manual micro-sequence analysis was carried out accord- 
ing to Chang [15] using the dimethylaminoazobenzene isothio- 
cyanate/phenylisothiocyanate (DABITC/PITC) double-coup- 
ling technique. 
Enzyme assays and other procedures 
Assay procedures of BtChE and aryl acylamidase, as well 
as enzyme units, were as described earlier [6]. 
The peptidase activity was assayed fluorometrically as de- 
scribed earlier [5] using the dipeptide Phe-Leu as substrate. 
The amount of the substrate hydrolyzed was determined from 
a standard curve obtained with known concentrations of an 
equimolar mixture of phenylalanine and leucine. One unit of 
peptidase activity is defined as the amount catalysing the 
liberation of 1 nmol each of phenylalanine and leucine/h. In 
some experiments [Leu'lenkephalin was also used as a sub- 
strate for measuring peptidase activity [5]. 
Protein was determined according to Lowry et al. [16] with 
crystalline bovine serum albumin as standard or by absor- 
bance at 280 nm for column effluents. 
Radioactivity due to [3H]iPr,P-labelling was determined 
by counting 0.1-ml samples in 3 ml Bray's scintillation fluid 
in dioxan [I71 in an LKB liquid scintillation counter. 
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Fig. 1. SDS-gel electrophoresis of purifkd human serum BtChE. (a) 
Purified enzyme stained with Coomassie brilliant blue. (b) Auto- 
radiogram of purified 1251-labelled enzyme subjected to electro- 
phoresis. (c) Autoradiogram of purified [3H]iPr,P-labelled enzyme 
subjected to electrophoresis 
Inhibit ion studies 
Inhibition studies were performed by pre-incubating the 
enzyme with the inhibitor for 10min at 37°C followed by 
assay. The inhibitors were added to the assay blanks also to 
avoid any interference by them. 
RESULTS 
SDSlpolyucrylumide gel electrophoresis 
of the unlahelled and labelled BtChE 
The SDS-gel electrophoresis pattern of the purified BtChE 
under reducing conditions is shown in Fig. 1. The monomeric 
form of the enzyme as a major protein band of = 90 kDa and 
the dimeric form of the enzyme as a minor band of = 180 kDa 
were seen, as observed by Lockridge et al. [18]. A similar kind 
of pattern was seen when purified BtChE was labelled with 
[3H]iPr2P-F or ' 251 followed by SDS-gel electrophoresis and 
autoradiography (Fig. 1). Both the monomer and dimer incor- 
porated radioactivity, the former to a much greater extent in 
comparison to the latter. The identical electrophoretic patterns 
of the unlabelled and labelled protein showed that it is essen- 
tially homogeneous. 
u-Chymotrypsin digestion and Sephadex C-75 gel filtration 
The Sephadex G-75 gel filtration pattern of the purified 
enzyme is shown in Fig. 2A. The elution profile showed the 
BtChE, aryl acylamidase and peptidase activities co-eluting 
as a single peak at the void volume. The ratios of BtChE/aryl 
acylamidase activity and BtChE/peptidase activity remained 
constant in all the eluted fractions. After digestion of the 
purified enzyme with chymotrypsin for 6 h and chromatog- 
raphy of the digested sample on Sephadex G-75, two peaks of 
co-eluting BtChE and aryl acylamidase activity were seen, one 
corresponding to the undigested enzyme and another to a 
smaller molecule of = 20 kDa (Fig. 2B). In our earlier study 
[6], we reported this z 20-kDa fragment exhibiting both aryl 
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Fig. 2. Sephadex G-75 chromatography and elution profile of ( A )  
purified BtChE and ( B )  BtChE digested with a-chyrnotrypsin fo r  6 h. 
Each fraction was assayed for BtChE ( O ) ,  aryl acylamidase (C)  
and peptidase ( A )  activity. Arrows (1) indicate the molecular mass 
standards used; (a) bovine serum albumin, 68 kDa; (b) carbonic 
anhydrase, 29 kDa; (c) cytochrome c, 12.4 kDa. Details of 
chromatography and chymotryptic digestion are given under Ma- 
terials and Methods 
acylamidase and BtChE activity. In the present study we deter- 
mined the peptidase activity exhibited by BtChE in the 
Sephadex G-75 fractions. Two peaks of peptidase activity were 
seen, one coinciding with the undigested enzyme and another 
at a molecular mass of = 50 kDa (Fig. 2B). The peptidase 
activity peaks were measurable using not only Phe-Leu as 
substrate but also with another known substrate [Leu'lenke- 
phalin (results not shown). Whereas the ~ 2 0 - k D a  peak 
showed both BtChE and aryl acylamidase activities, the = 50- 
kDa peak exhibited only peptidase activity. These results 
suggested that, apart from a = 20-kDa fragment exhibiting 
both cholinesterase and aryl acylamidase activity [6], a- 
chymotrypsin digestion of purified BtChE also gave rise to a 
z 50-kDa fragment exhibiting only the peptidase activity. 
Similar results as given above were obtained when BtChE 
was digested for 6 h with chymotrypsin coupled to Sepharose 
4B and the digest passed through the Sephadex G-75 column, 
thereby excluding the possibility of any peptidase activity 
arising from the a-chymotrypsin. Keeping the purified BtChE 
alone at pH 7.5 at 37°C for 6-12 h followed by passage 
through Sephadex G-75 or subjection to SDS-gel electro- 
phoresis did not provide any evidence for cleavage of BtChE, 
ruling out the possibility of any endogenous chymotrypsin- 
like activity in the purified BtChE. Moreover, a-chymotrypsin 
at the concentration used for digestion did not exhibit any 
peptidase activity towards Phe-Leu under the usual assay 
conditions. 
RCA,-Sepharose chromatography 
Purified BtChE and the associated aryl acylamidase and 
peptidase activities could fully bind to a Ricinus communis 
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Fig. 3. RCAl-Sepharose chromatography of ( A )  purified BtChE, ( B j  
BtChE digested with sc-chymotrypsin fo r  6 h and ( C )  the % 50-kDa 
fragment exhibiting peptidase activity recovered,frorn Sephadex G-75 
column. Each fraction was assayed for BtChE ( O ) ,  aryl acylamidase 
(0) and peptidase ( A )  activity. Arrow (1) indicates the start of elution 
with lactose. Details of chromatography and chymotryptic digestion 
are given under Materials and Methods 
agglutinin - Sepharose column and could be eluted to the 
extent of 97% (Fig. 3 A). In an earlier study [6], we showed that 
chymotryptic digestion of BtChE resulted in the formation of 
a = 20-kDa fragment that exhibited both aryl acylamidase 
and BtChE activities and that could not bind to RCAI- 
Sepharose. When we measured peptidase activity we found 
that all the peptidase activity in the chymotrypsin digest of 
BtChE could bind to RCAl-Sepharose and could be fully 
eluted (Fig. 3 B). The enzyme eluted from RCA,-Sepharose 
was subjected to Sephadex G-75 chromatography. Two peaks 
of peptidase activity, one at the void volume corresponding 
to the undigested BtChE and another at a molecular mass 
of = 50 kDa, were observed (result not shown). In further 
experiments, it was observed that the z50-kDa fragment 
which exhibited peptidase activity when obtained from the 
Sephadex G-75 column could completely bind to RCA1- 
Sepharose and be eluted to the extent of 94% (Fig. 3 C). These 
results suggested that, in addition to a = 20-kDa active protein 
fragment exhibiting both BtChE and aryl acylamidase activity 
that could not bind to RCA,-Sepharose, a z 50-kDa fragment 
exhibiting only peptidase activity that could fully bind to a 
RCA,-Sepharose column was formed by chymotryptic diges- 
tion of BtChE. 
SDS-gel electrophoresis of the low-molecular-mass fragments 
of BtChE obtained after chymotr-yptic digestion 
Purified BtChE showed a single major protein band of 
= 90 kDa as shown in Fig. 4A. After digestion of BtChE 
with a-chymotrypsin and passage through a RCA,-Sepharose 
column, the flow-through fraction, exhibiting aryl acyl- 
amidase and BtChE activities, and the eluted fractions, ex- 
hibiting BtChE, aryl acylamidase and peptidase activities, 
were subjected to SDS/PAGE. The BtChE fragment that did 
Fig. 4. SDS/polyaerylamide gel electrophoresis pattern of ( A )  purified 
BtChE, ( B j  the % 20-kDa chymotryptic fragment of purified BtChE 
isolated from of RCA,-Sepharose chromatog- 
raphy followed by Sephadex G-75 chromatography, ( C )  the pooled 
eluted fraction f rom RCA ,-Sepharose of the chymotryptic digest of 
purified BtChE, ( D j  the z 50-kDa chymotryptic fragment of purified 
BtChE exhibiting peptidase activity isolated bjl Sephadex G-75 
chromatography followed by RCA -Sepharose chromatography and 
elution. Lanes (A) and (B) were stained by Coomassie blue and lanes 
(C) and (D) by silver nitrate 
not bind to RCAl-Sepharose after isolation by Sephadex G- 
75 chromatography showed a single protein band of z 20 kDa 
as reported earlier [6] (Fig. 4B). The eluate from RCA1- 
Sepharose that showed BtChE, aryl acylamidase and 
peptidase activities gave two protein bands of z 90 kDa and 
z 50 kDa (Fig. 4C). The fragment that exhibited only 
peptidase activity isolated from the chymotryptic digest of 
BtChE by Sephadex G-75 chromatography gave a protein 
band of z 50 kDa on SDSjPAGE (Fig. 4D). These results 
confirmed that chymotryptic digestion of BtChE resulted in 
the formation of a z 50-kDa protein that exhibited peptidase 
activity exclusively and a z 20-kDa protein that exhibited 
both BtChE and aryl acylamidase activity. The results also 
indicated that the z 20-kDa fragment was devoid of galactose 
as reported earlier [6] but the z 50-kDa fragment contained 
galactose. 
Immunoprecipitation studies 
Polyclonal antibody raised against the purified BtChE 
could immunoprecipitate both the purified intact BtChE and 
the z 50-kDa fragment exhibiting peptidase activity (Fig. 5). 
Comparative characteristics of the z 50-kDa 
and z 20-kDa fragments with the parent enzyme 
As shown in Table 1, potent cholinesterase inhibitors like 
eserine, diisopropyl fluorophosphate and tetra-isopropyl- 
pyrophosphoramide had no inhibitory effect on the peptidase 
activity exhibited by the parent enzyme and the = 50-kDa 
fragment. There was a slight activation of the peptidase ac- 
tivity in the presence of eserine, tetra-isopropylpyrophos- 
phoramide and diisopropyl fluorophosphate as observed 
earlier [5] (Table 1). On the other hand, both cholinesterase 
and aryl acylamidase activities of the = 20-kDa fragment 
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Table 1. Ej@ct of various cholinesterase inhibitors on the enzyme activities exhibited by intact BtChE, N 50-kDa fragment and z 20-kDa,fragment 
Control enzyme activity in the absence of inhibitor is taken as 100% 
Inhibitor Concn Cholinesterase Pcptidase Aryl acylamidase 
parent ~ 2 0 - k D a  parent N 50-kDa parent z 20-kDa 
BtChE fragment BtChE fragment BtChE fragment 
mM % control 
Eserine 0.05 32 12 
0.10 16 0 
Procainamide 50 36 22 
100 6 0 
Tetra-isopropyl-pyrophosphoramide 0.005 0 0 
0.025 0 0 
Diisopropyl fluorophosphate 0.02 19 0 
0.10 0 0 
125 107 
132 128 
52 46 
52 50 
140 142 
148 152 
130 128 
138 136 
18 
7 
20 
7 
0 
0 
0 
0 
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Fig. 5. Immunoprecipitation of ( A )  purified BtChE and ( B j  the % 50- 
kDa fragment exhibiting peptidase activity by different concentrations 
of the antibudy raised against purgied BtChE. Both BtChE ( 0 )  and 
peptidase ( A )  activities were measured. Dctails of the experiment are 
given under Materials and Methods 
and the parent enzyme were significantly inhibited by these 
inhibitors. These results showed that the response towards the 
inhibitors by both the proteolytic fragments ( z  50 kDa and 
z 2 0  kDa) arising from the parent enzyme upon a- 
chymotrypsin digestion is similar to that of the parent enzyme. 
We have shown earlier that the aryl acylamidase activity 
of BtChE is inhibited by serotonin and activated by tyramine 
131. We examined the effect of these two biogenic amines on 
the aryl acylamidase activity of the w 20-kDa fragment and 
found that serotonin (1 - 10 mM) caused an inhibition of I0  - 
80% and tyramine (1 - 10 mM) stimulated the activity 2 - 12- 
fold, similar to findings made with the parent BtChE (data 
not shown). 
Amino-terminal sequence anulysis 
of the w SO-kDa protein fragment 
Purified BtChE was digested with a-chymotrypsin for 6 h, 
loaded onto the RCA,-Sepharose column and the eluted frac- 
tions from the RCA,-Sepharose were pooled and subjected to 
Sephadex G-75 gel filtration. The z 50-kDa fragment ex- 
hibiting peptidase activity was collected, dialyzed against 
water and used for amino-terminal sequence analysis. The 
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Fig. 6. Sephadex G-75 chromatography of [3H]iPr2P-labelled BtChE. 
The [3H]iPr2P-labelled BtChE or its chymotryptic digest (0.5-ml 
sample) was passed through a Sephadex G-75 column (36 x 1.1 cm) 
and eluted with 20 mM phosphate pH 7.2,O.OS M NaCI. Fractions of 
I ml were collected. Elution profile of (A) [3H]iPr,P-labelled purified 
BtChE, (B) r-chymotrypsin digest of [3H]iPr2P-labelled BtChE and 
(C) [3H]iPr,P-labelled BtChE in the presence of eserine followed by 
cr-chymotrypsin digestion are shown. The radioactivity of samples 
applied on Sephadex G-75 were different in each experiment, A, B 
and C. The molecular mass standards a, b and c are as mentioned in 
Fig. 2 
following N-terminal sequence of five amino acids was 
obtained: Gly-Pro-Thr-Val-Asp. This sequence was identical 
to the amino acid residues 291 -295 in the BtChE sequence 
given by Lockridge et al. [2]. 
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Fig. I .  Schematic diagram showing the major protein fraxments arising by limited a-chymotrypsin digestion of human serum BtChE and the nature 
of the fragments 
a-Chymotrypsin digestion and Sephadex G-75 chromatography 
of [ H ]  iPr2P-labelled Bt Ch E 
The [3H]iPr2P-labelled BtChE showed chromatographic 
behaviour on Sephadex G-75 identical to that of the unlabelled 
protein and emerged as a sharp peak at the void volume 
(Fig. 6A). The labelled BtChE was then digested with 
chymotrypsin for 6 h and the sample was loaded on the above 
column. Three peaks of radioactivity were seen on elution, 
one corresponding to the protein in the void volume, a second 
at a molecular mass corresponding to = 50 kDa and a third at 
a lower molecular mass corresponding to z 20 kDa (Fig. 6 B). 
Since the = 50-kDa fragment that exhibited peptidase activity 
did not show either cholinesterase or aryl acylamidase activity 
and was not sensitive to cholinesterase inhibitors, we were 
interested in seeing if the active site of the peptidase was 
distinct from the esteratic site of BtChE. We carried out 
[3H]iPrzP-labelling of BtChE in the presence and absence of 
eserine according to Small and Chubb as described under 
Methods [lo]. The labelled BtChE was then digested with a- 
chymotrypsin and subjected to Sephadex G-75 chromatog- 
raphy when three peaks of radioactivity were seen similar to 
the peaks shown in Fig. 6 B. The ratio of radioactivity of zz 50- 
kDa/=20-kDa fragments was 0.75 when the labelling was 
done in the absence of eserine and 0.71 when labelling was 
done in the presence of eserine (Fig. 6C). 
DISCUSSION 
Our previous work [3, 51 has shown that purified human 
serum BtChE exhibited an aryl acylamidase and a peptidase 
activity. In subsequent studies [6] we showed that limited a- 
chymotrypsin digestion of the purified human serum BtChE 
resulted in three major protein fragments of = 21 kDa, 
z 20 kDa and z 50 kDa on SDS-gel electrophoresis. The 
two low-molecular-mass fragments were stained well by 
Coomassie blue, while the = 50-kDa fragment was poorly 
stained and needed silver staining for detection. We character- 
ized [6] the = 20-kDa fragment and showed that it exhibited 
both BtChE and aryl acylamidase activities and that it had 
the N-terminal sequence Arg-Val-Gly-Ala-Leu which agreed 
with amino acid residues 147- 151 in the BtChE sequence 
given by Lockridge et al. [2]. We also showed that the z 20- 
kDa fragment was devoid of galactose and could not bind to 
RCAl-Sepharose, unlike the parent enzyme [6]. In the present 
study, we have characterized the = 50-kDa fragment that 
did not have cholinesterase or aryl acylamidase activity but 
exhibited a peptidase activity exclusively. This z 50-kDa frag- 
ment, which could be separated by Sephadex G-75 column 
chromatography, bound completely to a RCA,-Sepharose 
column indicating its glycosylated nature and the presence of 
galactose residues. The peptidase activity exhibited by the 
!z 50-kDa protein could be immunoprecipitated by a poly- 
clonal antibody raised against the purified parent BtChE. 
The response of both the = 20-kDa and = 50-kDa fragments 
towards cholinesterase inhibitors was similar to the parent 
enzyme. The z 50-kDa fragment did not involve the active- 
site Ser'98 residue, as evidenced by the N-terminal amino acid 
sequencing; this could explain the insensitivity of the peptidase 
activity in the parent BtChE [5], as well as the = 50-kDa 
fragment, to many classical cholinesterase inhibitors. How- 
ever the slight stimulatory effect of peptidase activity by these 
inhibitors [5] was retained by the z 50-kDa fragment. The 
overall results suggested that the FZ 20-kDa and z 50-kDa 
fragments obtained by chymotryptic cleavage of the parent 
BtChE still retained their binding sites for the inhibitors and 
behaved in a manner similar to the parent BtChE. 
When purified [3H]iPrzP-labelled BtChE was digested 
with chymotrypsin and subjected to Sephadex G-75 chroma- 
tography three peaks of radioactivity corresponding to the 
parent enzyme, z 50-kDa fragment and = 20-kDa fragment 
were seen. Since the z20-kDa fragment has an active-site 
serine residue, as reported earlier [6], the appearance of a 
radioactive peak for this fragment was understandable. The 
amino acid residue involved in the [3H]iPrzP-labelling of the 
= 50-kDa fragment is however not clear. Recently Small and 
Chubb [lo] reported that a trypsin-like endopeptidase activity 
was present in acetylcholinesterase and that it was associated 
with a serine residue at a site distinct from the esteratic site. 
We carried out preferential labelling with [3H]iPr2P-F as de- 
scribed by Small and Chubb [lo] in the presence and absence 
of eserine, an esteratic site inhibitor. If two distinct serine 
residues were responsible for the cholinesterase and peptidase 
activities then labelling with [3H]iPrzP-F for a short period in 
the absence ofeserine is expected to occur only on the esteratic 
site of BtChE and the addition of eserine is expected to block 
the esteratic site labelling of BtChE with the resulting incor- 
poration of radioactivity into the peptidase fragment only 
[lo]. In our experiment, both in the presence and absence of 
eserine, radioactivity from [3H]iPrzP-F was incorporated into 
the = 50-kDa and z 20-kDa protein fragments. It has been 
proposed that the active-site center of cholinesterase, in ad- 
dition to a reactive serine residue, may also include a histidyl 
residue involved in the catalytic triad [19, 201 which, however, 
has not yet been located. Ozols [21] has proposed that the 
iPrz P-binding histidine residue of a FZ 60-kDa glycoprotein 
esterase from liver microsomal membrane may correspond to 
His438 of serum cholinesterase, based on the sequence simi- 
larity between the two proteins. It is possible that the z 50- 
kDa fragment incorporates radioactivity from [3H]iPr2P-F at 
this histidyl residue. 
We reported earlier [6] that the partial manual sequencing 
of the N-terminal amino acids of the z20-kDa fragment 
showed the sequence Arg-Val-Gly-Ala-Leu which corresponds 
to the amino acid residues 147- 151 of BtChE [2]. Sequencing 
of the N-terminal amino acids of the % 50-kDa fragment 
showed the sequence Gly-Pro-Thr-Val-Asp, which agreed with 
amino acid residues 291 -295 in the BtChE sequence [2], 
suggesting that the chymotryptic cleavage generating the 
z 50-kDa fragment has taken place between Phe290 and 
GlyZ9l in the BtChE molecule. The scheme given in Fig. 7 
summarizes the conclusions and indicates the amino acid resi- 
dues encompassed by the three protein fragments arising from 
purified BtChE by a-chymotrypsin digestion. 
Finally, the identity of the five-amino-acid sequence at the 
N-terminus of the z 50-kDa fragment (exhibiting peptidase 
activity) with amino acid residues 291 -295 in the BtChE 
sequence [2] provides convincing evidence that the fragment 
exhibiting peptidase activity is part of the BtChE molecule. 
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